2490-full
btrflynana2
Sex: F
Data Quality: 0 stars
MSA: 8 yrs
Type: Multiple System Atrophy (MSA)
Mood: Very bad
Cognition: Moderate
Autonomic: Moderate
Head: none
Arms: none
Legs: moderate
Tremors: none
btrflynana2
Female, 55 years
BRENTWOOD, CA
Primary Condition
MSA
Type
Multiple System Atrophy (MSA)
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

btrflynana2's Comtan is for:

  • Other

btrflynana2 has not reported any side effects for Comtan.

btrflynana2's Comtan History (Stopped)
Comtan (entacapone)
800 mg Daily May 31 - Dec 23, 2008
Stopped Did not seem to work Dec 23, 2008
Evaluations
Date Dosage Other Perceived effectiveness Side Effects Adherence Burden
Nov 23, 2008 800 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Sep 16, 2008 800 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Date
Sep 16, 2008
Advice & Tips
Follow the medication plan that your doctor has designed for your situation
Cost
$50-99 monthly

About Comtan (Prescription Drug)

Comtan® is a brand name for the drug entacapone, a catechol-o-methyltransferase (COMT) inhibitor indicated as an adjunct treatment for patients taking levodopa and carbidopa for Parkinson’s Disease who experience the signs and symptoms of end-of-dose “wearing-off”.

Learn more about Comtan in our Comtan Community Report.